Sean Fenske, Editor-in-Chief03.12.24
A digital stethoscope—the ChestPal Pro—has been launched in the U.S. The portable device detects crackles and wheezes, aiding physicians in the diagnosis of respiratory conditions, including pneumonia, asthma, and COPD.
“ChestPal Pro helps pick up lung sounds that are too subtle to hear when using a stethoscope alone,” said Dr. Emily Tuchman, MD, General Internal Medicine. “I listened to a patient’s lungs with my stethoscope and didn’t auscultate wheezing, but with ChestPal Pro, I picked up wheezing and could prescribe the steroids and inhaler my patient needed to improve.”
According to the company, no other smart stethoscope has the clinical utility of this unit and its crackle/wheeze detection. In addition, the device converts lung sounds into visual spectrograms and also provides lung sound recording, monitoring, and transmission. Further, the device enables the sharing of lung exams, easing referrals.
“We created ChestPal Pro to make lung sound classification more objective and reliable for frontline healthcare professionals as part of their clinical decision-making process,” said Helena Binetskaya, co-founder and chief product officer, ChestPal Ltd.
“ChestPal Pro helps pick up lung sounds that are too subtle to hear when using a stethoscope alone,” said Dr. Emily Tuchman, MD, General Internal Medicine. “I listened to a patient’s lungs with my stethoscope and didn’t auscultate wheezing, but with ChestPal Pro, I picked up wheezing and could prescribe the steroids and inhaler my patient needed to improve.”
According to the company, no other smart stethoscope has the clinical utility of this unit and its crackle/wheeze detection. In addition, the device converts lung sounds into visual spectrograms and also provides lung sound recording, monitoring, and transmission. Further, the device enables the sharing of lung exams, easing referrals.
“We created ChestPal Pro to make lung sound classification more objective and reliable for frontline healthcare professionals as part of their clinical decision-making process,” said Helena Binetskaya, co-founder and chief product officer, ChestPal Ltd.